SAD and MAD Study of KH001 in Dentin Hypersensitivity Patients
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This is a phase 1/2a study in dentin hypersensitivity patients to assess the safety,
tolerability, efficacy and pharmacokinetics of single and multiple doses of KH001.